Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population

Suvi R K Hokkanen, Sally Hunter, Tuomo M Polvikoski, Hannah A D Keage, Thais Minett, Fiona E Matthews, Carol Brayne, MRC CFAS and CC75C Study Group, Suvi R K Hokkanen, Sally Hunter, Tuomo M Polvikoski, Hannah A D Keage, Thais Minett, Fiona E Matthews, Carol Brayne, MRC CFAS and CC75C Study Group

Abstract

Hippocampal neuron loss is a common neuropathological feature in old age with various underlying etiologies. Hippocampal sclerosis of aging (HS-Aging) is neuropathologically characterized by severe CA1 neuronal loss and frequent presence of transactive response DNA-binding protein of 43 kDa (TDP-43) aggregations. Its etiology is unclear and currently no standardized approaches to measure HS-Aging exist. We developed a semi-quantitative protocol, which captures various hippocampal neuron loss patterns, and compared their occurrence in the context of HS-Aging, TDP-43, vascular and tau pathology in 672 brains (TDP-43 staining n = 642/672, 96%) donated for the population-based Cambridge City over-75s Cohort and the Cognitive Function and Ageing Study. HS-Aging was first evaluated independently from the protocol using the most common criteria defined in literature, and then described in detail through examination of neuron loss patterns and associated pathologies. 34 (5%) cases were identified, with a maximum of five pyramidal neurons in each of over half CA1 fields-of-view (x200 magnification), no vascular damage, no neuron loss in CA2-CA4, but consistent TDP-43 neuronal solid inclusions and neurites. We also report focal CA1 neuron loss with vascular pathology to affect predominantly CA1 bordering CA2 (Fisher's exact, P = 0.009), whereas neuron loss in the subicular end of CA1 was associated with TDP-43 inclusions (Fisher's exact, P < 0.001) and high Braak stage (Fisher's exact, P = 0.001). Hippocampal neuron loss in CA4-CA2 was not associated with TDP-43. We conclude that hippocampal neuron loss patterns are associated with different etiologies within CA1, and propose that these patterns can be used to form objective criteria for HS-Aging diagnosis. Finally, based on our results we hypothesize that neuron loss leading to HS-Aging starts from the subicular end of CA1 when it is associated with TDP-43 pathology, and that this neurodegenerative process is likely to be significantly more common than "end-stage" HS-Aging only.

Keywords: TDP-43; hippocampal sclerosis; hippocampus; neuron loss; population study.

© 2017 The Authors Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Figures

Figure 1
Figure 1
HS‐Aging neuropathological characteristics on hematoxylin‐eosin‐staining. A. Hippocampal formation without significant pathological findings. Hippocampal subfields are marked. B. A hippocampus with HS‐Aging shows severe atrophy and complete neuron loss, and gliosis in the whole CA1 area and subiculum (arrowheads). Other hippocampal areas appear intact. C. Microglia and pale eosinophilic astrocytes populate the CA1 region in HS‐Aging. Magnifications: (A, B): 2.5x; scale bar (C): 50 μm. DG = Dentate Gyrus, Sub = Subiculum.
Figure 2
Figure 2
Schematic illustration of the hippocampal neuron loss scoring protocol workflow. Example (A) explains the scoring of a case with extensive severe neuron loss in CA1, and example (B) shows a case with a focal lesion in CA1 bordering CA2.
Figure 3
Figure 3
TDP‐43 inclusions and neurites pathology prevalence and severity in the hippocampus and entorhinal cortex by HS‐Aging status. All HS‐Aging cases were positive for dentate inclusions (A) as well as neurites (B) were significantly more prevalent and severe in all hippocampal regions compared to non‐HS‐Aging cases. Analogous, entorhinal cortex inclusions (C) and neurites (D) prevalence and severity were significantly higher in HS‐Aging than the remainder cohort. **P < 0.001, NSCI = TDP‐43‐positive neuronal solid cytoplasmic inclusions; SN = TDP‐43‐positive short neurites; HS = hippocampal sclerosis of aging.
Figure 4
Figure 4
Focal neuron loss characteristics in different locations of the CA1 sector. (A) Focal neuron loss due to a microinfarct in the beginning of the CA1. The circle marks (B), one field‐of‐view at 200x magnification showing a localized, well circumscribed complete loss of neurons, and a glial scar. (C) Focal neuron loss in the subicular end of CA1, possibly associated with neurodegeneration. Neurons are preserved more proximal of the lesion (arrowheads). The circle marks (D), one field‐of‐view at 200x magnification showing disseminated gliosis and severe neuron loss, without indications of a microinfarct. Scale bars: (A, C): 200 μm; (B, D): 100 μm. (E) Among cases with neuron loss, lesions in the CA2‐bordering third of CA1 are most likely affected with ischemia (*P = 0.009), whereas neuron loss with TDP‐43 inclusions associates with the subicular end of CA1 (**P < 0.001). NSCI = neuronal solid cytoplasmic inclusions.

References

    1. Ala TA, Beh GO, Frey WH 2nd (2000) Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology 54:843–848.
    1. Amador‐Ortiz C, Ahmed Z, Zehr C, Dickson DW (2007) Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol 113:245–252.
    1. Amador‐Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R et al (2007) TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435–445.
    1. Amaral D, Insausti R (1990) Hippocampal Formation. In: The Human Nervous System, Paxinos G (ed.), Chapter 21 pp. 711–755. Elsevier, Academic Press.
    1. Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ et al (2015) Disease‐related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3:32.
    1. Bandopadhyay R, Liu JY, Sisodiya SM, Thom M (2014) A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia. Neuropathol Appl Neurobiol 40:177–190.
    1. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D et al (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16:203–212.
    1. Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D et al (2003) Hippocampal sclerosis dementia with tauopathy. Brain Pathol 13:263–278.
    1. Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A et al (2013) International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia 54:1315–1329.
    1. Blümcke I, Zuschratter W, Schewe JC, Suter B, Lie AA, Riederer BM et al (1999) Cellular pathology of hilar neurons in Ammon's horn sclerosis. J Comp Neurol 414:437–453.
    1. Bondareff W, Wischik CM, Novak M, Roth M (1991) Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 139:641–647.
    1. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol 82:239–259.
    1. Brayne C, McCracken C, Matthews FE (CFAS) MRCCFaAS (2006) Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol 35:1140–1145.
    1. Chui H (2005) Neuropathology lessons in vascular dementia. Alzheimer Dis Assoc Disord 19:45–52.
    1. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ et al (2006) Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 60:677–687.
    1. Corey‐Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ (1997) Hippocampal sclerosis contributes to dementia in the elderly. Neurology 48:154–160.
    1. Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S et al (2011) TDP‐43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703–713.
    1. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E et al (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol 88:212–221.
    1. Fleming J, Zhao E, O'Connor DW, Pollitt PA, Brayne C (2007) Cohort profile: the Cambridge City over‐75s Cohort (CC75C). Int J Epidemiol 36:40–46.
    1. Gwet KL (2008) Computing inter‐rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol 61:29–48.
    1. Gwet KL (2012) Handbook of Inter‐Rater Reliability. 3rd Edition, Advanced Analytics, LLC.
    1. Hatanpaa KJ, Blass DM, Pletnikova O, Crain BJ, Bigio EH, Hedreen JC et al (2004) Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 63:538–542.
    1. Hatanpaa KJ, Raisanen JM, Herndon E, Burns DK, Foong C, Habib AA, White CL (2014) Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J Neuropathol Exp Neurol 73:136–142.
    1. Ighodaro ET, Jicha GA, Schmitt FA, Neltner JH, Abner EL, Kryscio RJ et al (2015) Hippocampal sclerosis of aging can be segmental: two cases and review of the literature. J Neuropathol Exp Neurol 74:642–652.
    1. Jellinger KA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old humans. Acta Neuropathol 88:599.
    1. Josephs KA, Dickson DW (2007) Hippocampal sclerosis in tau‐negative frontotemporal lobar degeneration. Neurobiol Aging 28:1718–1722.
    1. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW (2006) Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 63:1632–1638.
    1. Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M et al (2008) Abnormal TDP‐43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850–1857.
    1. Joshi A, Teng E, Tassniyom K, Mendez MF (2014) Hippocampal and mesial temporal sclerosis in early‐onset frontotemporal lobar degeneration vs. Alzheimer's disease. Am J Alzheimers Dis Other Demen 29:45–49.
    1. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174.
    1. Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D et al (2002) Clinical and neuropathological characteristics of hippocampal sclerosis: a community‐based study. Arch Neurol 59:1099–1106.
    1. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P (2009) Epidemiological pathology of dementia: attributable‐risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 6:e1000180.
    1. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486.
    1. Murray ME, Cannon A, Graff‐Radford NR, Liesinger AM, Rutherford NJ, Ross OA et al (2014) Differential clinicopathologic and genetic features of late‐onset amnestic dementias. Acta Neuropathol 128:411–421.
    1. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E et al (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134:1506–1518.
    1. Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH et al (2013) Hippocampal sclerosis of aging, a prevalent and high‐morbidity brain disease. Acta Neuropathol 126:161–177.
    1. Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA et al (2014) Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137:255–267.
    1. Neltner JH, Abner EL, Jicha GA, Schmitt FA, Patel E, Poon LW et al (2016) Brain pathologies in extreme old age. Neurobiol Aging 37:1–11.
    1. Nikonenko AG, Radenovic L, Andjus PR, Skibo GG (2009) Structural features of ischemic damage in the hippocampus. Anat Rec (Hoboken) 292:1914–1921.
    1. Onken M, Berger S, Kristian T (2012) Simple model of forebrain ischemia in mouse. J Neurosci Methods 204:254–261.
    1. Onyike CU, Pletnikova O, Sloane KL, Sullivan C, Troncoso JC, Rabins PV (2013) Hippocampal sclerosis dementia: an amnesic variant of frontotemporal degeneration. Dement Neuropsychol 7:83–87.
    1. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff‐Radford NR (2011) Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 25:364–368.
    1. Probst A, Taylor KI, Tolnay M (2007) Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114:335–345.
    1. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non‐Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10:180–188.
    1. Rauramaa T, Pikkarainen M, Englund E, Ince PG, Jellinger K, Paetau A, Alafuzoff I (2013) Consensus recommendations on pathological changes in the hippocampus: a postmortem multi‐center inter‐rater study. J Neuropathol Exp Neurol 72:452–461.
    1. Rössler M, Zarski R, Bohl J, Ohm TG (2002) Stage‐dependent and sector‐specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol 103:363–369.
    1. Ryufuku M, Toyoshima Y, Kitaura H, Zheng Y, Fu YJ, Miyahara H et al (2011) Hypertrophy of hippocampal end folium neurons in patients with mesial temporal lobe epilepsy. Neuropathology 31:476–485.
    1. Scheller MS, Grafe MR, Zornow MH, Fleischer JE (1992) Effects of ischemia duration on neurological outcome, CA1 histopathology, and nonmatching to sample learning in monkeys. Stroke 23:1471–1476.
    1. Schmitz C, Hof PR (2005) Design‐based stereology in neuroscience. Neuroscience 130:813–831.
    1. Sommer W (1880) Erkrankung des Ammonshornes als aetiologisches Moment der Epilepsie. Archiv für Psychiatrie und Nervenkrankheiten 10: 31–675.
    1. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769–772.
    1. West MJ, Gundersen HJ (1990) Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296:1–22.
    1. White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA et al (2016) Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu‐Asia Aging Studies. Neurology 86:1000–1008.
    1. Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C et al (2000) Neuropathological findings in the very old. Results from the first 101 brains of a population‐based longitudinal study of dementing disorders. Ann N Y Acad Sci 903:490–496.
    1. Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T et al (2010) Phosphorylated TDP‐43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55–66.
    1. Zarow C, Sitzer TE, Chui HC (2008) Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr Neurol Neurosci Rep 8:363–370.
    1. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC (2005) Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 57:896–903.
    1. Zarow C, Weiner MW, Ellis WG, Chui HC (2012) Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav 2:435–442.

Source: PubMed

3
Tilaa